<?xml version="1.0" encoding="iso-8859-1" ?>
<rss version="2.0" xmlns:s="http://resources.bnet.com/">
<channel>
	<title><![CDATA[european patent office Resources | BNET]]></title>
	<link><![CDATA[http://resources.bnet.com/topic/european+patent+office.html]]></link>
	<description><![CDATA[White papers, case studies, business articles, and blog posts relating to european patent office]]></description>
	<s:counts start="0" returned="20" found="272" />
	<language>en-us</language>
	<item>
		<title><![CDATA[Europe Taking Up Question of Software Patentability]]></title>
		<link><![CDATA[http://industry.bnet.com/technology/1000508/europe-taking-up-question-of-software-patentability/]]></link>
		<description><![CDATA[This must be a day for patent news. Earlier, the U.S. Court of Appeals for the Federal Circuit reaffirmed the previous In Re Bilski case so that, barring some reversal by the U.S. Supreme Court, a huge number of business method patents will be invalid, including software patents and financial...]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Thu, 30 Oct 2008 21:02:42 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/software.html"><![CDATA[Software]]></category>
		<category domain="http://resources.bnet.com/topic/patent.html"><![CDATA[Patent]]></category>
		<category domain="http://resources.bnet.com/topic/software+patent.html"><![CDATA[Software Patent]]></category>
		<category domain="http://resources.bnet.com/topic/tools+%2526+techniques.html"><![CDATA[Tools & Techniques]]></category>
		<category domain="http://resources.bnet.com/topic/management.html"><![CDATA[Management]]></category>
		<category domain="http://resources.bnet.com/topic/erik+sherman.html"><![CDATA[Erik Sherman]]></category>
		<category domain="http://resources.bnet.com/topic/software.html"><![CDATA[Software]]></category>
		<category domain="http://resources.bnet.com/topic/patent.html"><![CDATA[Patent]]></category>
		<category domain="http://resources.bnet.com/topic/european+patent+office.html"><![CDATA[European Patent Office]]></category>
		<category domain="http://resources.bnet.com/topic/software+patent.html"><![CDATA[Software Patent]]></category>
		<category domain="http://resources.bnet.com/topic/tools+%2526+techniques.html"><![CDATA[Tools & Techniques]]></category>
		<category domain="http://resources.bnet.com/topic/management.html"><![CDATA[Management]]></category>
		<category domain="http://resources.bnet.com/topic/erik+sherman.html"><![CDATA[Erik Sherman]]></category>
	</item>
	<item>
		<title><![CDATA[Nanobiotix Announces Issue of European Patent Protecting Its nanoXray&#153; Anticancer Platform]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2008_Sept_22/ai_n28573160]]></link>
		<description><![CDATA[PARIS -- Nanobiotix, an emerging nanomedicine company focused on cancer therapy, announced today that the European Patent Office EPO has issued Patent No. 1744789 to the Company, related to its "novel activable particles that can be used in the health sector."  More specifically, the patent protects "composite particles that...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Mon, 22 Sep 2008 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/benefits.html"><![CDATA[Benefits]]></category>
		<category domain="http://resources.bnet.com/topic/cell.html"><![CDATA[cell]]></category>
		<category domain="http://resources.bnet.com/topic/european+patent+office.html"><![CDATA[European Patent Office]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[HEALTHCARE]]></category>
		<category domain="http://resources.bnet.com/topic/nanotechnology.html"><![CDATA[Nanotechnology]]></category>
		<category domain="http://resources.bnet.com/topic/particle.html"><![CDATA[particle]]></category>
		<category domain="http://resources.bnet.com/topic/software.html"><![CDATA[SOFTWARE]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[CruiseCam International Moves Forward With Patents in Europe]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_pwwi/is_200808/ai_n27976145]]></link>
		<description><![CDATA[CruiseCam International, Inc. (PINKSHEETS: CCMJ), after years in the process of review by the European Patent Office EPO, has been allowed the use of a number of critical claims that will comprise the basis of its first European patents pertaining to seat-integrated video recording technology. Through the successful efforts of...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Thu, 07 Aug 2008 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/company.html"><![CDATA[Company]]></category>
		<category domain="http://resources.bnet.com/topic/cruisecam+international+inc..html"><![CDATA[CruiseCam International Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/european+patent+office.html"><![CDATA[European Patent Office]]></category>
		<category domain="http://resources.bnet.com/topic/marketing.html"><![CDATA[MARKETING]]></category>
		<category domain="http://resources.bnet.com/topic/patent.html"><![CDATA[patent]]></category>
		<category domain="http://resources.bnet.com/topic/video.html"><![CDATA[video]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">CCMJ</category>
		<category domain="tickers">CCMJ</category>
	</item>
	<item>
		<title><![CDATA[Clinical Data Secures EU Patent for MDR1 - A Key Multi-Drug Resistance Gene]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2008_June_26/ai_n27871198]]></link>
		<description><![CDATA[Gene Linked to Response to Many Classes of Medications  NEWTON, Mass. -- Clinical Data, Inc. (NASDAQ: CLDA), a leader in the development of targeted therapeutics and predictive tests from its growing portfolio of proprietary genetic biomarkers, announced today that the European Patent Office has granted Patent No. 1232260 to...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Thu, 26 Jun 2008 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/benefits.html"><![CDATA[Benefits]]></category>
		<category domain="http://resources.bnet.com/topic/european+patent+office.html"><![CDATA[European Patent Office]]></category>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[FINANCE]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[HEALTHCARE]]></category>
		<category domain="http://resources.bnet.com/topic/investment.html"><![CDATA[Investment]]></category>
		<category domain="http://resources.bnet.com/topic/patent.html"><![CDATA[patent]]></category>
		<category domain="http://resources.bnet.com/topic/readers.html"><![CDATA[READERS]]></category>
		<category domain="http://resources.bnet.com/topic/software.html"><![CDATA[SOFTWARE]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Critical Outcome Technologies Inc. Announces Granting of European Patents for Acute Myelogenous Leukemia Drug Candidates]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_pwwi/is_200805/ai_n25390117]]></link>
		<description><![CDATA[Critical Outcome Technologies Inc. (TSX VENTURE: COT), announced today that patents to its novel drug candidates for the treatment of Acute Myelogenous Leukemia AML have recently been granted by the European Patent Office. The patents have been granted under European patent numbers 1 551 824 and 1 542 989 and...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Wed, 07 May 2008 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/european+patent+office.html"><![CDATA[European Patent Office]]></category>
		<category domain="http://resources.bnet.com/topic/patent.html"><![CDATA[patent]]></category>
		<category domain="http://resources.bnet.com/topic/patient.html"><![CDATA[patient]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[SCIENCE AND RESEARCH : CREATOR OF MP3 STANDARD NOMINATED FOR TOP EUROPEAN PRIZE.]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb6638/is_200804/ai_n26528706]]></link>
		<description><![CDATA[The Italian inventor who spearheaded the creation of global  standards for digital audio and video, the Belgian virologist who gave  hope to HIV patients and the Airbus team who made plane engines less  noisy have all been nominated for the Inventor of the Year 2008 awards. ...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Wed, 23 Apr 2008 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/european+patent+office.html"><![CDATA[European Patent Office]]></category>
		<category domain="http://resources.bnet.com/topic/marketing.html"><![CDATA[MARKETING]]></category>
		<category domain="http://resources.bnet.com/topic/mp3.html"><![CDATA[MP3]]></category>
		<category domain="http://resources.bnet.com/topic/quality.html"><![CDATA[Quality]]></category>
		<category domain="http://resources.bnet.com/topic/standards.html"><![CDATA[standards]]></category>
		<category domain="http://resources.bnet.com/topic/video.html"><![CDATA[video]]></category>
	</item>
	<item>
		<title><![CDATA[PATENT POLICY : EPO: APPLICATIONS RISE BUT FEWER PATENTS GRANTED.]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb6638/is_200804/ai_n26528682]]></link>
		<description><![CDATA[The number of patent applications in Europe increased  last year to  the highest level in recent history, but the number of granted patents  was one of the lowest in the last five years. Statistics published by  the European Patent Office EPO, on 1 April, show that...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Wed, 09 Apr 2008 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/european+patent+office.html"><![CDATA[European Patent Office]]></category>
		<category domain="http://resources.bnet.com/topic/patent.html"><![CDATA[patent]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[EUROPEAN PATENT OFFICE : APPLICATIONS RISE BUT FEWER PATENTS GRANTED.]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb6463/is_200804/ai_n25682858]]></link>
		<description><![CDATA[The number of patent applications in Europe increased  last year to  the highest level in recent history, but the number of granted patents  was one of the lowest in the last five years. Statistics published by  the European Patent Office EPO, on 1 April, show that...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Mon, 07 Apr 2008 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/european+patent+office.html"><![CDATA[European Patent Office]]></category>
		<category domain="http://resources.bnet.com/topic/patent.html"><![CDATA[patent]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Neptune Technologies Patent Granted for Novel Phospholipids in Multiple Diseases and Pharmaceutical Applications.]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb5570/is_200803/ai_n25297173]]></link>
		<description><![CDATA[LAVAL, Canada, March 27 /PRNewswire/ --     - Composition of Matter Patent Granted and Enforceable in 24  European Countries     - Competitors Precluded From Immediate Commercialisation of  Competitive Products     Neptune Technologies & Bioressources Inc. ("Neptune")  (NASDAQ: NEPT...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Thu, 27 Mar 2008 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/company.html"><![CDATA[Company]]></category>
		<category domain="http://resources.bnet.com/topic/european+patent+office.html"><![CDATA[European Patent Office]]></category>
		<category domain="http://resources.bnet.com/topic/patent.html"><![CDATA[patent]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[African American-Owned Company Canady Technology to Seek Twenty-Six Million Dollars in Damages against ConMed Corporation and Attorney Fees in Excess of Five Hundred Thousand Dollars against Erbe Elektromedizin GmbH]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2008_March_10/ai_n24383992]]></link>
		<description><![CDATA[PITTSBURGH -- Despite recent legal decisions against Erbe in the U.S. International Trade Commission and the U.S. District Court for the Western District of Pennsylvania and a prior decision against ConMed in the arbitration it instituted against Canady Technology, negotiations over the last six weeks between Canady Technology, Erbe and...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Mon, 10 Mar 2008 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/arbitration.html"><![CDATA[arbitration]]></category>
		<category domain="http://resources.bnet.com/topic/biomedical.html"><![CDATA[biomedical]]></category>
		<category domain="http://resources.bnet.com/topic/conmed+corp..html"><![CDATA[Conmed Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/european+patent+office.html"><![CDATA[European Patent Office]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[HEALTHCARE]]></category>
		<category domain="http://resources.bnet.com/topic/llc.html"><![CDATA[LLC]]></category>
		<category domain="http://resources.bnet.com/topic/m.d..html"><![CDATA[M.D.]]></category>
		<category domain="http://resources.bnet.com/topic/patent.html"><![CDATA[patent]]></category>
		<category domain="http://resources.bnet.com/topic/pennsylvania.html"><![CDATA[Pennsylvania]]></category>
		<category domain="http://resources.bnet.com/topic/u.s.+district+court.html"><![CDATA[U.S. District Court]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">CNMD</category>
		<category domain="tickers">CNMD</category>
	</item>
	<item>
		<title><![CDATA[NewCardio Receives European Patent for CardioBip&#153;]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2008_March_4/ai_n24361453]]></link>
		<description><![CDATA[European Patent Office Approves Patent for Device and Methodology for Transtelephonic Transmission of ECG Data for Monitoring of Acute Cardiac Conditions  SAN JOSE, Calif. -- NewCardio, Inc. (OTCBB: NWCI), a development-stage cardiac diagnostic and services company, announced today that it has received a Certificate of Grant from the European...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Tue, 04 Mar 2008 23:59:59 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/european+patent+office.html"><![CDATA[European Patent Office]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[HEALTHCARE]]></category>
		<category domain="http://resources.bnet.com/topic/monitoring.html"><![CDATA[monitoring]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Neptune Technologies Patent Granted for Novel Phospholipids in Multiple Diseases and Pharmaceutical Applications.]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb6487/is_200803/ai_n25822664]]></link>
		<description><![CDATA[Neptune Technologies & Bioressources Inc. (Laval, Canada) said  the European Patent Office granted on May 31st 2007 Neptune's  composition of matter patent entitled, "Natural Marine Source  Phospholipids comprising flavonoids, polyunsaturated fatty acids and  their applications" (EP01417211B1) and that this patent has now  been issued and...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Sat, 01 Mar 2008 23:59:59 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/european+patent+office.html"><![CDATA[European Patent Office]]></category>
		<category domain="http://resources.bnet.com/topic/patent.html"><![CDATA[patent]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[OREXIGEN&#153; Therapeutics Announces European Patent Office Allows Composition and Use Claims for its Patent on Contrave&#153; to Treat Obesity]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2008_Feb_28/ai_n24354114]]></link>
		<description><![CDATA[--Clears the Way for Possible Development of Contrave in Europe--  SAN DIEGO -- OrexigenTM Therapeutics, Inc. (Nasdaq: OREX), a biopharmaceutical company focused on the treatment of central nervous system disorders, including obesity, today announced that the European Patent Office has issued a Decision to Grant a Patent covering compositions...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Thu, 28 Feb 2008 23:59:59 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/european+patent+office.html"><![CDATA[European Patent Office]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[HEALTHCARE]]></category>
		<category domain="http://resources.bnet.com/topic/patent.html"><![CDATA[patent]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Corgenix Announces Issuance of European Patent for Aspirin Resistance Testing]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2008_Feb_21/ai_n24318709]]></link>
		<description><![CDATA[Corgenix Licensed Technology Adds Patent #EP 1 488 232 B1, a Method and Device for Rapid Detection of Aspirin Resistance as an Indicator of the Risk of Cardiovascular Events  DENVER -- Corgenix Medical Corporation (OTCBB: CONX), a worldwide developer and marketer of diagnostic test kits, has received notification of...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Thu, 21 Feb 2008 23:59:59 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/aspirin.html"><![CDATA[aspirin]]></category>
		<category domain="http://resources.bnet.com/topic/european+patent+office.html"><![CDATA[European Patent Office]]></category>
		<category domain="http://resources.bnet.com/topic/patent.html"><![CDATA[patent]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Occlutech Wins Confirmation of its Intellectual Property Position Versus AGA Medical Patent by AIPPI.]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb5570/is_200802/ai_n25295627]]></link>
		<description><![CDATA[JENA, Germany, February 7 /PRNewswire/ --     Occlutech GmbH, the  leading European manufacturer of coronary occlusion devices today  announced that it has obtained approval for its IP position in relation  to patents held by AGA Medical Inc. from AIPPI, the European  International Association...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Thu, 07 Feb 2008 23:59:59 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/european+patent+office.html"><![CDATA[European Patent Office]]></category>
		<category domain="http://resources.bnet.com/topic/germany.html"><![CDATA[Germany]]></category>
		<category domain="http://resources.bnet.com/topic/ip.html"><![CDATA[IP]]></category>
		<category domain="http://resources.bnet.com/topic/networking.html"><![CDATA[NETWORKING]]></category>
		<category domain="http://resources.bnet.com/topic/patent.html"><![CDATA[patent]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Rohm & Haas earns patent for Neolone CapG blend]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb3042/is_2_45/ai_n29412833]]></link>
		<description><![CDATA[European Patent Office: Has awarded the patent for Neolone CapG technology, a synergistic blend of methylisothiazolinone and caprylyl glycol to Rohm & Haas.]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Fri, 01 Feb 2008 23:59:59 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/blend.html"><![CDATA[blend]]></category>
		<category domain="http://resources.bnet.com/topic/european+patent+office.html"><![CDATA[European Patent Office]]></category>
		<category domain="http://resources.bnet.com/topic/patent.html"><![CDATA[patent]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Inventors boosted by cut in translation costs.]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb5243/is_200801/ai_n25246551]]></link>
		<description><![CDATA[M2 PRESSWIRE-31 January 2008-UK Government: Inventors boosted by  cut in translation costsC1994-2008 M2 COMMUNICATIONS LTD     RDATE:31012008     INVENTORS and businesses in the UK are set to save more than GBP10  million a year thanks to new patent legislation which does away...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Thu, 31 Jan 2008 23:59:59 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/european+patent+office.html"><![CDATA[European Patent Office]]></category>
		<category domain="http://resources.bnet.com/topic/patent.html"><![CDATA[patent]]></category>
		<category domain="http://resources.bnet.com/topic/ratification.html"><![CDATA[ratification]]></category>
		<category domain="http://resources.bnet.com/topic/u.k..html"><![CDATA[U.K.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Aero Performance Products, Inc. Announces Progress of EU Patent Protection as Part of European Expansion Strategy]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_pwwi/is_200801/ai_n21214311]]></link>
		<description><![CDATA[Aero Performance Products, Inc. (PINKSHEETS: AERP), which operates Aero Exhaust, Inc., a world leader in performance exhaust airflow technology and NASCAR Performance Partner, today announced that it has received preliminary approval from the European Patent Office for the patent application on Aero's product technology in 18 European countries.  The...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Mon, 28 Jan 2008 23:59:59 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/european+patent+office.html"><![CDATA[European Patent Office]]></category>
		<category domain="http://resources.bnet.com/topic/nascar.html"><![CDATA[NASCAR]]></category>
		<category domain="http://resources.bnet.com/topic/patent.html"><![CDATA[patent]]></category>
		<category domain="http://resources.bnet.com/topic/performance.html"><![CDATA[performance]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[AMT's Lead Product Poised to Address Major Liver Disease.]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb5570/is_200801/ai_n23687584]]></link>
		<description><![CDATA[AMSTERDAM, The Netherlands, January 28 /PRNewswire/ --     - European Patent Office Grants Patent for Treatment of  Non-Alcoholic  Steatotic Hepatitis     AMT (Euronext: AMT), a leader in the field of human gene therapy,  today  announced that the European Patent Office...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Mon, 28 Jan 2008 23:59:59 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/amsterdam.html"><![CDATA[Amsterdam]]></category>
		<category domain="http://resources.bnet.com/topic/european+patent+office.html"><![CDATA[European Patent Office]]></category>
		<category domain="http://resources.bnet.com/topic/patent.html"><![CDATA[patent]]></category>
		<category domain="http://resources.bnet.com/topic/patient.html"><![CDATA[patient]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[AMT's Lead Product Poised to Address Major Liver Disease; European Patent Office Grants Patent for Treatment of Non-alcoholic Steatotic Hepatitis.]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb5243/is_200801/ai_n25244888]]></link>
		<description><![CDATA[M2 PRESSWIRE-28 January 2008-AMT: AMT's Lead Product Poised to  Address Major Liver Disease; European Patent Office Grants Patent for  Treatment of Non-alcoholic Steatotic HepatitisC1994-2008 M2  COMMUNICATIONS LTD     RDATE:28012008     Amsterdam, The Netherlands -- AMT (Euronext: AMT), a leader in the...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Mon, 28 Jan 2008 23:59:59 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/amsterdam.html"><![CDATA[Amsterdam]]></category>
		<category domain="http://resources.bnet.com/topic/european+patent+office.html"><![CDATA[European Patent Office]]></category>
		<category domain="http://resources.bnet.com/topic/molecular+inc..html"><![CDATA[Molecular Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/patent.html"><![CDATA[patent]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
</channel>
</rss>
